We know that no one eats, sleeps and breathes bioprinting like CELLINK does. Since we’re constantly developing new capabilities for the scientists we support, we’re always following industry trends and researching what will be the next big thing in the field. We’ve summed up our top five bioprinting predictions below!
- More options will be enabled in materials and blended material applications.
Technologies like AI are helping us determine the right combinations of biomaterials for turning scaffolds into tissue. To keep up with advancing theories, we predict that vendors will prioritize material development as well as bioprinting systems with more printheads to support using more bioinks on a single print.
- Continued enhancements will be made to optimize software.
Even the best designed hardware can’t succeed without great software. CELLINK was one of the first companies to provide features like remote monitoring and cloud-based software, and we think that enabling more materials and capabilities will underscore the need for software that’s refreshed, intuitive and designed with the user in mind.
- More business sectors will adopt bioprinting solutions.
Already, government space agencies and bioprinting companies have collaborated to test and validate tissue model performance in the harshest environment known to man. As rugged studies continue returning with positive results, it will be even easier for new business sectors to get started with leveraging bioprinting capabilities in their market.
Do you agree with our predictions? Are we missing something? Let us know! Find us on social media and tell us what you think: